RENOVACARE, INC.

RCAR
Delayed Quote. Delayed  - 10/26 12:25:48 pm
3.6USD -2.17%
Prev.3.6800
Open3.6100
High3.6100
Low3.6000
Volume1 325
Latest news
4d ago
4d ago
10/06
10/06
Chart RENOVACARE, INC.
Financials
Sales 2019 - - -
Net income 2019 -3,36 M - -
Net cash 2019 12,2 M - -
P/E ratio 2019 -83,1x
Yield 2019 -
Capitalization 314 M 314 M -
EV / Sales 2018 -
EV / Sales 2019 -
Nbr of Employees -
Free-Float 37,5%
Company
RenovaCare, Inc. is a biotechnology company. The Company is focused on the acquisition, research, development and, if warranted, commercialization of autologous (using a patient’s own cells) cellular therapies that can be used for medical and aesthetic applications. The CellMist System includes a...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
No events available

Income Statement Evolution